ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 572,41
-0,79%
Dow Jones
40 211,72
0,53%
DAX
18 506,86
-0,50%
Brent Oil
83,30
-1,23%
Bitcoin
63 368,98
-2,29%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Nightstar Therapeutics Plc ADS (NITE)

  7. Nightstar Therapeutics Plc ADS (NITE) Actualités

NITE

Nightstar Therapeutics Plc ADS (NITE)

Nightstar Therapeutics Plc ADS
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NITE
DateHeureSourceTitreSymboleSociété
14/02/202023h22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NITENightstar Therapeutics Plc ADS
17/06/201922h03Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:NITENightstar Therapeutics Plc ADS
12/06/201921h52Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NITENightstar Therapeutics Plc ADS
11/06/201922h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NITENightstar Therapeutics Plc ADS
10/06/201923h22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:NITENightstar Therapeutics Plc ADS
10/06/201923h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NITENightstar Therapeutics Plc ADS
07/06/201914h28Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:NITENightstar Therapeutics Plc ADS
07/06/201911h44GlobeNewswire Inc.Nightstar Therapeutics PLC Completion of Acquisition by BiogenNASDAQ:NITENightstar Therapeutics Plc ADS
07/06/201911h41GlobeNewswire Inc.Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 MillionNASDAQ:NITENightstar Therapeutics Plc ADS
05/06/201914h33GlobeNewswire Inc.Nightstar Therapeutics plc Court Approval Received in Connection With Acquisition by BiogenNASDAQ:NITENightstar Therapeutics Plc ADS
29/05/201915h00GlobeNewswire Inc.Nightstar Therapeutics plc Update to Timetable Relating to the Acquisition by BiogenNASDAQ:NITENightstar Therapeutics Plc ADS
10/05/201912h03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NITENightstar Therapeutics Plc ADS
08/05/201915h36GlobeNewswire Inc.Nightstar Therapeutics PLC Shareholders Approve Scheme of Arrangement for Acquisition By Biogen at General Meeting and Court ...NASDAQ:NITENightstar Therapeutics Plc ADS
30/04/201922h30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NITENightstar Therapeutics Plc ADS
30/04/201922h17Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NITENightstar Therapeutics Plc ADS
26/04/201908h00GlobeNewswire Inc.Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Nightstar Shareholders Vote “FOR” Proposed Acquisition by Biog...NASDAQ:NITENightstar Therapeutics Plc ADS
25/04/201917h51Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NITENightstar Therapeutics Plc ADS
16/04/201914h35GlobeNewswire Inc.Nightstar Therapeutics plc Announcement of Expiry of HSR Waiting Period and Satisfaction of Antitrust ConditionNASDAQ:NITENightstar Therapeutics Plc ADS
10/04/201916h21Edgar (US Regulatory)Schedule 13gNASDAQ:NITENightstar Therapeutics Plc ADS
09/04/201915h15Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:NITENightstar Therapeutics Plc ADS
09/04/201914h55GlobeNewswire Inc.Recommended Acquisition of Nightstar Therapeutics plc by Tungsten Bidco Limited, a Wholly-Owned Subsidiary of Biogen Switzerl...NASDAQ:NITENightstar Therapeutics Plc ADS
18/03/201922h33Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NITENightstar Therapeutics Plc ADS
18/03/201922h26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NITENightstar Therapeutics Plc ADS
18/03/201914h31Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:NITENightstar Therapeutics Plc ADS
04/03/201915h07Dow Jones NewsNightstar Therapeutics Shares Surge on Biogen DealNASDAQ:NITENightstar Therapeutics Plc ADS
04/03/201913h12Dow Jones NewsBiogen Expands Into Gene Therapy for Eye DiseaseNASDAQ:NITENightstar Therapeutics Plc ADS
04/03/201912h35Dow Jones NewsBiogen to Buy Nightstar Therapeutics for $25.50 a ShareNASDAQ:NITENightstar Therapeutics Plc ADS
04/03/201908h01GlobeNewswire Inc.Nightstar Therapeutics plc reaches agreement to be acquired by BiogenNASDAQ:NITENightstar Therapeutics Plc ADS
14/02/201921h47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NITENightstar Therapeutics Plc ADS
13/02/201922h57Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:NITENightstar Therapeutics Plc ADS
 Showing the most relevant articles for your search:NASDAQ:NITE

Dernières Valeurs Consultées

LSE
CEPS
Ceps
LSE
0G2P
Santierul Naval Orsova
LSE
MDOB
Mandarin Oriental Intern...
LSE
DNLM
Dunelm
EU
CARP
Carpinienne de Participa...
NYSE
CTLT
Catalent
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés